NASDAQ:SNSS - Sunesis Pharmaceuticals News Headlines

$0.91
+0.06 (+7.06 %)
(As of 07/17/2019 04:00 PM ET)
Today's Range
$0.84
Now: $0.91
$0.93
50-Day Range
$0.57
MA: $0.74
$0.98
52-Week Range
$0.20
Now: $0.91
$2.60
Volume64,256 shs
Average Volume1.40 million shs
Market Capitalization$66.00 million
P/E RatioN/A
Dividend YieldN/A
Beta2.75

Headlines

Sunesis Pharmaceuticals (NASDAQ SNSS) News Headlines

Source:
DateHeadline
 Analysts Anticipate Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Will Announce Earnings of -$0.10 Per Share Analysts Anticipate Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Will Announce Earnings of -$0.10 Per Share
www.americanbankingnews.com - July 17 at 10:19 AM
How Many Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Shares Do Institutions Own?How Many Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Shares Do Institutions Own?
finance.yahoo.com - July 15 at 6:25 PM
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Major Shareholder Buys $1,500,000.00 in StockSunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Major Shareholder Buys $1,500,000.00 in Stock
www.americanbankingnews.com - July 15 at 5:23 PM
Sunesis prices stock offering; shares down 27% premarketSunesis prices stock offering; shares down 27% premarket
seekingalpha.com - July 11 at 8:44 AM
Sunesis Announces Pricing of $25 Million Offering of SecuritiesSunesis Announces Pricing of $25 Million Offering of Securities
finance.yahoo.com - July 11 at 8:44 AM
Sunesis readies stock offering; shares down 27% after hoursSunesis readies stock offering; shares down 27% after hours
seekingalpha.com - July 10 at 6:23 PM
Sunesis Pharmaceuticals Announces Executive Promotions and Provides Clinical UpdateSunesis Pharmaceuticals Announces Executive Promotions and Provides Clinical Update
finance.yahoo.com - July 8 at 8:46 AM
 Brokerages Expect Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) to Post -$0.10 EPS Brokerages Expect Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) to Post -$0.10 EPS
www.americanbankingnews.com - June 24 at 6:45 AM
Options Traders Expect Huge Moves in Sunesis (SNSS) StockOptions Traders Expect Huge Moves in Sunesis (SNSS) Stock
finance.yahoo.com - June 17 at 7:29 PM
Sunesis Pharmaceuticals Announces Presentation of Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies at EHA Annual MeetingSunesis Pharmaceuticals Announces Presentation of Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies at EHA Annual Meeting
feeds.benzinga.com - June 15 at 1:30 PM
Edited Transcript of SNSS earnings conference call or presentation 8-May-19 8:30pm GMTEdited Transcript of SNSS earnings conference call or presentation 8-May-19 8:30pm GMT
finance.yahoo.com - May 9 at 8:48 AM
Sunesis Pharmaceuticals Reports First Quarter 2019 Financial Results and Recent HighlightsSunesis Pharmaceuticals Reports First Quarter 2019 Financial Results and Recent Highlights
www.globenewswire.com - May 8 at 7:17 PM
Sunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q1 20189 Results - Earnings Call TranscriptSunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q1 20189 Results - Earnings Call Transcript
seekingalpha.com - May 8 at 7:17 PM
Whats in the Cards for Sunesis (SNSS) This Earnings Season?What's in the Cards for Sunesis (SNSS) This Earnings Season?
finance.yahoo.com - May 1 at 7:08 PM
Sunesis Pharmaceuticals to Host Conference Call on May 8th to Discuss First Quarter 2019 Financial Results and Recent HighlightsSunesis Pharmaceuticals to Host Conference Call on May 8th to Discuss First Quarter 2019 Financial Results and Recent Highlights
finance.yahoo.com - May 1 at 8:40 AM
Sunesis Pharmaceuticals Announces Refinancing of Existing Loan with $5.5 Million Loan from Silicon Valley BankSunesis Pharmaceuticals Announces Refinancing of Existing Loan with $5.5 Million Loan from Silicon Valley Bank
finance.yahoo.com - April 29 at 6:24 PM
Biotechs Strive to Provide Patients With More Affordable Treatment OptionsBiotechs Strive to Provide Patients With More Affordable Treatment Options
www.marketwatch.com - April 11 at 9:46 AM
Sunesis Pharmaceuticals to Present at 18th Annual Needham & Company Healthcare ConferenceSunesis Pharmaceuticals to Present at 18th Annual Needham & Company Healthcare Conference
finance.yahoo.com - April 3 at 9:26 AM
Will Sunesis Pharmaceuticals Continue to Surge Higher?Will Sunesis Pharmaceuticals Continue to Surge Higher?
finance.yahoo.com - March 15 at 7:04 PM
Sunesis Pharmaceuticals down 7% on Q4 resultsSunesis Pharmaceuticals down 7% on Q4 results
seekingalpha.com - March 8 at 7:30 PM
Sunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q4 2018 Results - Earnings Call TranscriptSunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 8 at 8:56 AM
Edited Transcript of SNSS earnings conference call or presentation 7-Mar-19 9:30pm GMTEdited Transcript of SNSS earnings conference call or presentation 7-Mar-19 9:30pm GMT
finance.yahoo.com - March 8 at 8:56 AM
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent HighlightsSunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Highlights
finance.yahoo.com - March 7 at 6:36 PM
Sunesis Pharmaceuticals to Participate in Upcoming Investor ConferencesSunesis Pharmaceuticals to Participate in Upcoming Investor Conferences
finance.yahoo.com - March 4 at 11:17 AM
Sunesis Pharmaceuticals to Host Conference Call on March 7th to Discuss Fourth Quarter and Full-Year 2018 Financial Results and Recent Highlights - NasdaqSunesis Pharmaceuticals to Host Conference Call on March 7th to Discuss Fourth Quarter and Full-Year 2018 Financial Results and Recent Highlights - Nasdaq
www.nasdaq.com - February 28 at 6:41 PM
Sunesis Pharmaceuticals to Host Conference Call on March 7th to Discuss Fourth Quarter and Full-Year 2018 Financial Results and Recent HighlightsSunesis Pharmaceuticals to Host Conference Call on March 7th to Discuss Fourth Quarter and Full-Year 2018 Financial Results and Recent Highlights
finance.yahoo.com - February 28 at 8:56 AM
Sunesis prices $20M equity offeringSunesis prices $20M equity offering
seekingalpha.com - January 18 at 9:26 AM
Sunesis Announces Proposed Public Offering of Common Stock and Preferred StockSunesis Announces Proposed Public Offering of Common Stock and Preferred Stock
finance.yahoo.com - January 17 at 6:53 PM
Sunesis advancing blood cancer candidate vecabrutinibSunesis advancing blood cancer candidate vecabrutinib
seekingalpha.com - January 2 at 5:13 PM
Sunesis Pharmaceuticals initiates 100mg cohort of Phase 1b/2 trial of Vecabrutinib in patients with CLLSunesis Pharmaceuticals initiates 100mg cohort of Phase 1b/2 trial of Vecabrutinib in patients with CLL
seekingalpha.com - January 2 at 5:13 PM
Sunesis Pharmaceuticals Announces Advancement into 100mg Cohort of Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell MalignanciesSunesis Pharmaceuticals Announces Advancement into 100mg Cohort of Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies
finance.yahoo.com - January 2 at 8:45 AM
UPDATE: HC Wainwright Starts Sunesis Pharmaceuticals Inc. (SNSS) at Neutral - StreetInsider.comUPDATE: HC Wainwright Starts Sunesis Pharmaceuticals Inc. (SNSS) at Neutral - StreetInsider.com
www.streetinsider.com - December 20 at 8:46 AM
The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFOThe Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO
www.msn.com - December 4 at 8:51 AM
Sunesis Pharma down 34% on vecabrutinib dataSunesis Pharma down 34% on vecabrutinib data
seekingalpha.com - December 3 at 4:58 PM
Sunesis Pharmaceuticals Announces Presentation of...Sunesis Pharmaceuticals Announces Presentation of...
www.benzinga.com - December 2 at 5:20 PM
Sunesis Pharmaceuticals Announces Presentation of Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies at ASH Annual MeetingSunesis Pharmaceuticals Announces Presentation of Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies at ASH Annual Meeting
finance.yahoo.com - December 2 at 5:20 PM
Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis PharmaceuticalsZacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals
finance.yahoo.com - November 29 at 9:05 AM
Sunesis Pharmaceuticals to Provide Program Update for Non-Covalent BTK-Inhibitor Vecabrutinib at Analyst & Investor Event during ASH 2018Sunesis Pharmaceuticals to Provide Program Update for Non-Covalent BTK-Inhibitor Vecabrutinib at Analyst & Investor Event during ASH 2018
globenewswire.com - November 28 at 8:56 AM
Sunesis Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare ConferenceSunesis Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 19 at 8:38 AM
Report: Developing Opportunities within NeuroMetrix, Sunesis Pharmaceuticals, Siga Technologies, NexPoint ...Report: Developing Opportunities within NeuroMetrix, Sunesis Pharmaceuticals, Siga Technologies, NexPoint ...
www.nasdaq.com - November 16 at 8:36 AM
Sunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q3 2018 Results - Earnings Call TranscriptSunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 6 at 8:43 AM
Sunesis: 3Q Earnings SnapshotSunesis: 3Q Earnings Snapshot
finance.yahoo.com - November 6 at 8:43 AM
Edited Transcript of SNSS earnings conference call or presentation 5-Nov-18 9:30pm GMTEdited Transcript of SNSS earnings conference call or presentation 5-Nov-18 9:30pm GMT
finance.yahoo.com - November 6 at 8:43 AM
Sunesis Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent HighlightsSunesis Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Highlights
finance.yahoo.com - November 5 at 5:05 PM
Sunesis Pharmaceuticals Announces Presentations at 60th American Society of Hematology Annual MeetingSunesis Pharmaceuticals Announces Presentations at 60th American Society of Hematology Annual Meeting
finance.yahoo.com - November 1 at 5:32 PM
Sunesis Pharmaceuticals to Host Conference Call on November 5th to Discuss Third Quarter 2018 Financial Results ...Sunesis Pharmaceuticals to Host Conference Call on November 5th to Discuss Third Quarter 2018 Financial Results ...
globenewswire.com - October 30 at 8:44 AM
Sunesis Pharmaceuticals to Host Conference Call on November 5th to Discuss Third Quarter 2018 Financial Results and Recent HighlightsSunesis Pharmaceuticals to Host Conference Call on November 5th to Discuss Third Quarter 2018 Financial Results and Recent Highlights
finance.yahoo.com - October 29 at 10:00 AM
Sunesis Pharmaceuticals to Present at the 2018 Cantor Global Healthcare ConferenceSunesis Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference
finance.yahoo.com - September 26 at 8:52 AM
Should You Worry About The Sunesis Pharmaceuticals Inc’s (NASDAQ:SNSS) Shareholder Register?Should You Worry About The Sunesis Pharmaceuticals Inc’s (NASDAQ:SNSS) Shareholder Register?
finance.yahoo.com - September 12 at 4:38 PM
Sunesis Pharmaceuticals to Present at the Wells Fargo Securities 2018 Healthcare ConferenceSunesis Pharmaceuticals to Present at the Wells Fargo Securities 2018 Healthcare Conference
finance.yahoo.com - August 30 at 8:55 AM
This page was last updated on 7/17/2019 by MarketBeat.com Staff

Featured Article: What is the Current Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel